RxDoctor Payments Data

Matthew Parrish, DO

Family Medicine · Tampa, FLNPI 1750949673

Payments from drug & device makers

$595in general payments, 2019–2025

Across 26 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$151
  • Gilead$88
  • Pfizer$82
  • Bayer$55
  • Novo Nordisk$48
  • Lilly USA, LLC$31
  • plus $140 from 8 others

What the payments were for

  • Food & beverage$595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$595 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$4,087
Medicare patients
11
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban101$97,906
JardianceEmpagliflozin38$52,593
OzempicSemaglutide38$43,602
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$26,691
MounjaroTirzepatide24$24,830
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$19,703
XareltoRivaroxaban11$17,790
FarxigaDapagliflozin Propanediol11$16,536
SymbicortBudesonide/Formoterol Fumarate34$10,424
MyrbetriqMirabegron11$7,525
Albuterol Sulfate HfaAlbuterol Sulfate177$5,597
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$5,129
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen166$4,439
Novolog FlexpenInsulin Aspart11$3,580
Oxybutynin Chloride74$3,475

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$82$97,906101 claims
Boehringer IngelheimJardiance$17$52,59338 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$151$46,66473 claims
Novo NordiskOzempic$48$43,60238 claims
Lilly USA, LLCMounjaro$31$24,83024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →